be considered as being composed of six regions or sub-regions, K, I-A, I-B, I-C, S, D* (for review, see . Originally anti I-a sera were induced through immunisation between strains carrying recombinant haplotypes such that donor and recipient shared in common all the genes of the H-2complex except those of the Z region (David et al. 1973 , Hauptfeld et al. 1973 . It is now apparent that many immune sera induced against the products of the whole H-2 haplotype contain both anti-H-2 (K and/or D) and anti-Ia antibodies , Sachs & Cone 1975 . When strains carrying the appropriate recombinant haplotypes are available, their lymphocytes can be used for selective absorption of anti-H-2 antibodies. On the other hand, the different tissue distribution of H-2 and Ia antigens should also permit the absorption of anti-H-2 antibodies. Contrary to H-2 antigens which are expressed on almost all tissues (Snell & Stimpfling 19641 , la antigens are detected only on certain cells-essentially B lymphocytes, macrophages, epidermal cells and sperm cells , Hauptfeld et al. 1974 , Unanue et al. 1974 . They are also expressed on thymocytes but probably more weakly and/or only on a subpopulation of these cells , Fre-*The "haplotype composition" of a given strain when mentioned in this report refers to the genes of the H-2 complex at the six regions or subregions listed in the order, K , I-A, I-B, I-C. S , D. The nomenclature for the H-2 complex and the Ia antigens will be as recently proposed (Klein et a] . 1974, . Whenever possible without ambiguity the H-2 haplotype will be designated by the italicized superscript symbol printed on line with the text (e.g. k for H-Zk).
Abbreviations used in this paper: LCT: dye exclusion lymphocytotoxicity technique; LyCF: spleen lymphocyte complement fixation technique; PICF: pIatelet Complement fixation technique. linger et al. 1974a) . Ia antigens are not detected on erythrocytes, o r on kidney, liver and brain tissues . Erythrocytes and T cell tumors have already been used for the selective absorption of anti-H-2 antibodies (Davies & Hess 1974 , Sachs &Cone 1975 . It will be shown in this report that blood platelets can be very effective for this absorption.
We have already shown (Colombani et al. 1975 ) by a direct platelet complement fixation test (PICF) and by absorption-elution analyses that platelets carry a substantial number of H-2 antigens without detectable Ia antigens. For that reason sera reacting with the lymphocytes, but not with the platelets, of a given strain are very likely to contain anti-Ia antibodies. Such a study has been done on 20 immune sera, 12 of which were shown to contain well-defined anti-Ia antibodies in addition to anti-H-2 antibodies. A detailed study of one of these sera showed that the separation of anti-H-2 and anti-Ia antibodies can be easily obtained. Another serum developed against the products of the H-2k haplotype defined three new Ia specificities which will be described.
Materials and Methods
Animals and reagents: Inbred mouse strains and FI hybrids used in this study were all derived from the colony maintained in the Department of Human Genetics, University of Michigan. Immune sera were produced as previously described (Shreffler et al. 1966) .
Preparation of cells: Spleen lymphocytes used for absorption or lymphocyte complement fixation (LyCF) were purified by flotation on Ficoll-Sodium metrizoate solution (Thorsby & Bratlie 1970) , then washed and suspended in saline containing 0.1% NaNs and 0.1% bovine serum albumin, at the concentration of 20,000 cells/Pl. Lymph node lymphocytes were prepared without flotation. The lymphocytes used for absorption were a mixture of lymph node and spleen lymphocytes approximately in equal numbers. They were used less than 24 h after preparation.
Blood platelets were obtained by differential centrifugation from peripheral blood. The bleeding was made from the retroorbital sinus and the blood immediately mixed in a plastic tube with saline containing 5% Na:, EDTA in the proportion of 4 vol of blood for 1 vol of anticoagulant solution. The platelets were then sedimented by centrifugation (1,600 g/20 min/4"C) and washed three times in saline. They were finally suspended in saline containing 0.1% NaN3 at the concentration of 4 x 106/pl and kept at +4"C until used. They could be kept u p to one month without any appreciable change in antigenic activity. The yield of platelet preparations was 0.95 5 0.15 x lo9 per ml of blood for 53 preparations made in 18 differentstrains.The suspensions contained less than 1 leucocyte/1,000 platelets. The same platelet suspensions were used for absorption and PlCF.
Serological tests: Dye exclusion LCT (David et al. 1973 , Frelinger et al. 1974a ), LyCF and PlCF (Colombani et al. 1975 ) microtechniques were performed as previously described. In all cases unabsorbed rabbit serum was used as the source of complement.
Absorption-elution:
Absorptions were made by incubation for 30 minor 1 h at 37°C of an appropriate dilution of immune serum with an appropriate number of platelets or lyrnphocytes. After sensitization the cells were washed and elution performed in a small volume of saline acidified (pH 3.0) with HCl 0.1N. After 20 min at room temperature the suspension was centrifuged and the supernatant decanted and neutralized (pH 7.0) with NaOH 0.04 N (Schulman et al. 1964) .
Results '
Screening for sera containing anti-Ia antibodies; Twenty immune sera were produced by immunization against strains carrying the H-2 haplotypes b, d, f, k, p, 9, r, s (nos. 1-20 in Table 1 ) . In 15 cases the donor-recipient combination allowed immunization against products of the whole H-Zcomplex. In four cases immunization against the products of the H-2D region was "blocked" by the presence of an allele shared in common by donor and recipient. In one case (serum no. 6), immunization against the products of the H-ZK, I-A and I-B regions was similarly blocked.
The reactivity of the sera was studied against a panel of 15 strains carrying nine independent H-2 haplotypes (b, d, f, j , k, p, 9, r, s) and six recombinant haplotypes (tl, y l , h4, a, i5, t4) (see list of the strains in Table 2) , by the LCT, LyCF and PlCF techniques. Essentially two patterns of reactivity were observed-the H-2 pattern, LCT(+) with 100% of lymphocyte killing, LyCF(+), PlCF(+)-and the Ia-pattern, LCT(+) with a maximum lymphocyte killing less than 75%, LyCF(+), PlCF(-). T h e H-2 pattern was observed against the immunizing strain, or the strains carrying at the H-2K and/or D regions the same genes as the immunizing strain. The Ia pattern was observed in strains with recombinant haplotypes when the target strain shared part of all of the I region with the immunizing strain. In addition, a number of cross-reactions of both anti-H-2 and anti-Ia antibodies were observed, as expected from the H-2 (Demant 1973) and Ia charts.
All sera contained the anti-H-2K and/or D antibodies expected from the immunization Combination (Table 1) . T w o sera contained only anti-H-2 antibodies (nos. 5 and 6). Twelve sera contained, in addition, well characterized anti-la antibodies-Ia.2 (no. 7), Ia.1, 2, 3 (nos. 8 and 9), Ia.8 (no. 3 (63) 320 (73) 80(58) 160 (66) H-2 haplotypes j , r, s, t3, t4, i3, i5 . All these latter reactions followed the Ia pattern and were not altered by absorption with BIO.K platelets. In addition, serum no. 21 ( q x d) anti-yl which could contain only anti-Ia antibodies, reacted identically with serum no. 7 absorbed on BIO.K platelets or with the unabsorbed serum (except for an l a pattern of reaction instead of the H-2 pattern against BlO.K, BIO.A and BlO.A(4R) ).
An absorption-elution experiment using the lymphocytes of the strongly reacting strains was carried out in order to analyse these Ia reactions (Table 3 ). In every case the absorption was adequate since it removed all reactivity against the absorbing cells. B 10.K lymphocytes carrying the immunizing haplotype cleared all reactivity. On the other hand, all the other cells tested failed to absorb the anti-H-2.23 antibody reacting with BIO.K lymphocytes and in addition left unabsorbed one or more antiIa antibodies (including anti-Ia.2) reacting with AQR lymphocytes. T h e absorption by B1O.S lymphocytes of the reactivity against BI0.M target cells (Ia. 1(+)) suggested that serum no. 7 did not contain the expected anti-Ia. 1 antibody since B 1O.S is Ia. 1 (-). In addition, B1O.S cannot possess any la antigen cross-reacting with Ia.1 since the original anti-Ia.1 antibody was made in a recipient strain carrying the same s genes as B1O.S at the Z region (David et al. 1973) .
The results of absorption could be explained by three specificities X, Y and 2 , distributed as indicated in Table 3 (in addition to Ia.2). BIO.M and B1O.S behaved identically (cross-absorption); this showed that both strains carry the same specificities (X and Y ) . Specificity X is present on all the cells used for absorption; and is the only one carried by B 1 O.WB since all cells cleared the reactivity against B 10.WB lymphocytes. On the other hand, as absorption on B1O.WB lymphocytes left some reactivity against the other cells, other specificities were involved. At least two distinct specificities (Y and Z) were needed since there was no crossabsorption between B1O.RIII (Z) on the one hand and B1O.M or B1O.S ( Y ) on the other. All eluates were reactive against all targets in agreement with the hypothesis of one specificity (X) shared in common by all strains used for absorption.
An unexpected result was the reactivity remaining against B 1O.S (9R) lymphocytes after absorption on B1O.S and BIO.M lymphocytes. It was finally removed by a higher number of B1O.S lymphocytes. But even then B1O.M lymphocytes were ineffective. These results could be compared to the weak reactivity of sera nos. 7 and 2 1 against B 1 O.A(3R) and B lO.A(5R) ( Table 2 ) and will be discussed later.
Discussion
The presence of H-2 antigens on blood platelets has already been reported (Schanzer et al. 1974) and their H-2 antigenic content evaluated (1 lymphocyte -30 platelets) (Colombani et al. 1975 ). The present evaluation (1 lymphocyte -100 platelets) was somewhat lower. Such variations are likely to be due to experimental conditions, to the properties and perhaps the specificity of the antibody used for quantitative absorption. The best average estimate could then be 1 lymphocyte -50 platelets. Ia antigens were not detectable on platelets, and their maximum amount estimated was less than 1:35 relative to the H-2 antigenic content, which protably reflects a complete absence of Ia antigens. These results are in agreement with the ubiquitous distribution of H-2 antigens, and the restricted distribution of la antigens.
The description of Ia antigens depends o n the production of appropriate antisera. Specific anti-Ia antibodies can be induced in donor-recipient combinations where (61) 80 (54) 80(50) 40 (60) 160(65) 320(71) 160 (50) 160(50) XY xz 320 (68) 640 ( ' For acid elution 1 x los lymphocytes were sensitized with 100pLof undilutedserum. After washing, the elution was made in a volume of 50pL. All sera and eluates were tested against C3H.Q lymphocytes with negative results. serum no. 7 in which the anti-H-2 antibody titre was 1:320 (after absorption on AQR lymphocytes, Table 3 ) while the anti-Ia titre was l:G40-1:1280 (after absorption on BIO.K platelets, Table 2 ). These experiments showed also that anti-H-2 and anti-la antibodies could be easily eluted from their antigens at low pH.
As shown by the study of 20 immune sera essentially developed against the products of the whole H-2 complex, the association of anti-Ia to anti-H-2 antibodies is very frequent. More than half of the sera contained both kinds of antibodies. This observation together with the possibility of selective absorption of anti-H-2 antibodies on platelets from the immunizing slrain, suggests that this approach will be useful for the description of new Ia specificities, particularly for the study of Ia antigens determined by haplotypes for which no recombinants are presently available.
It is already apparent that a large number of distinct Ia specificities are determined at the three (or more) loci of the I region -I-A, I-B, I-C . Analyses of two anti-H-2' sera (nos. 7 and 21) made possible the description of three new Ia specificities. They are distinct from the specificities already described as determined by the H-2' haplotype (Ia.1, 2, 3, 7) on the basis of their strain distributions, and because, of these specificities, serum no. 7 could contain antibody only to Ia.2, since immunization against Ia.3 and 7 was blocked by the recipient combination. Absence of anti-Ia. 1 was shown by absorption analysis. These new Ia specificities are indeed determined at the I region and most likely by the I-A and/or I-B subregion as shown by the reactivity of serum DO. 7 against AQR lymphocytes and of serum no. 21 against the panel. In both cases the antibodies could be directed only against the products of k genes at the I-A and/or I-B loci; in addition, the identical reactivities of the two sera suggested that they contained the same anti-Ia antibodies. Finally, the fact that BIO.K platelets failed to absorb these antibodies confirmed that the antigens recognized are not H-2K or H-2D products.
The results of absorption with the reactive lymphocytes (Table 3) showed that three different specificities were involved, X (which w e propose to call Ia.17) determined by H-2 haplotypes k, f, s, r, j, Y (Ia.18) determined by haplotypes k, f, s, Z (Ia.19 determined by haplotypes k and r.
A recent study (Gotze 1975 Even with these new specificities certain facts remained unexplained-the difficulty in absorbing out the reactivity of serum no. 7 against BlOS(9R) lymphocytes with B1O.S and BIO.M lymphocytes, and the weak reactivity of both no. 7 and no. 21 sera against BlO.A(JR) and BlO.A(5R) lymphocytes. Some of these reactions might have been attributed to an anti-Tla.1, 3 antibody which could have been produced in both sera (Frelinger et al. 1974b )-(q, Tla" x d, Tla') anti-k or anti-y1, both Tlu"; BIO.S(SR), BIO.A(5R) are T l a a (BlO.A(SR) is also very likely T l u " ) . However, both sera were non-reactive against B 1 O.A(GR) which is also Tla" (Table 2) , and BIO.M(Tlaa) lymphocytes did not absorb all reactivity against BlO.S(SR). The possibility of these weak reactions being due to an anti-Tla. 1 , 3 antibody was thus ruled out. Another possibility was that the recombinant haplotypes (t4, i3, i5) carried a chromosomal segment of k origin located between the I-B and I-C subregions. This hypothesis is compatible with the origin of these recombinants from the H-2" haplotype (haplotype composition kkkddd) which should then carry the same k segment. Moreover, this segment should also be present in the H-2Y' haplotype of AQR, whose lymphocytes were used for immunization in the production by B1O.S and BI0.M of the reactivity against BIO.S(SR). The complete absorption obtained by increasing the amount of B1O.S lymphocytes would have to be due to nonspecific absorption of a weak antibody. This hypothesis would also explain the reactivity of both immune sera against BIO.A(SR) and BlO.A(5R) lymphocytes (bbbddd) even though BIOlSn (bbbbb) and B10.DZ (ddddd) are non-reactive as they are due to the same k segment derived from H-2". Experiments are in progress to test this hypothesis (Sachs et al. 1975, David & Shreffler, in preparation) .
